Skip to main content
Erschienen in: European Radiology 5/2015

01.05.2015 | Neuro

Discriminating pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors by means of susceptibility-weighted imaging

verfasst von: Jui-Hsun Fu, Tzu-Chao Chuang, Hsiao-Wen Chung, Hing-Chiu Chang, Huey-Shyan Lin, Shu-Shong Hsu, Po-Chin Wang, Shuo-Hsiu Hsu, Huay-Ben Pan, Ping-Hong Lai

Erschienen in: European Radiology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the feasibility of using susceptibility-weighted imaging (SWI) to discriminate abscesses and necrotic tumours.

Methods

Twenty-one patients with pyogenic abscesses, 21 patients with rim-enhancing glioblastomas and 23 patients with rim-enhancing metastases underwent SWI. Intralesional susceptibility signal (ILSS) was analyzed employing both qualitative (QL) and semi-quantitative (SQ) methods. Logistic regression models and receiver operating characteristic analysis were used to demonstrate the discriminating power.

Results

In QL analysis, ILSSs were seen in 12 of 21 abscesses, in 20 of 21 glioblastomas, and in 16 of 23 metastases. In SQ analysis, a low degree of ILSS (85.8 %) was in the majority of abscesses and a high degree of ILSS (76.2 %) was in the majority of glioblastomas. SQ model was significantly better than QL model in distinguishing abscesses from glioblastomas (P < .001). A derived ILSS cutoff grade of 1 or less was quantified as having a sensitivity of 85.7 %, specificity of 90.5 %, accuracy of 88.1 %, PPV of 90.0 %, and NPV of 86.4 % in distinguishing abscesses from glioblastomas.

Conclusions

A high-grade ILSS may help distinguish glioblastomas from abscesses and necrotic metastatic brain tumours. The lack of ILSS or low-grade ILSS can be a more specific sign in the imaging diagnosis of abscesses.

Key Points

• ILSS of SWI can contribute to differential diagnosis of rim-enhanced mass.
• Low-grade ILSS can be a more specific sign in abscesses.
• High-grade ILSS may help distinguish necrotic glioblastomas from abscesses.
• ILSS spreads across the four ILSS categories in metastases.
Literatur
1.
Zurück zum Zitat Lau DW, Klein NC, Cunha BA (1989) Brain abscess mimicking brain tumor. Heart Lung 18:634–637PubMed Lau DW, Klein NC, Cunha BA (1989) Brain abscess mimicking brain tumor. Heart Lung 18:634–637PubMed
2.
Zurück zum Zitat Mamelak AN, Mampalam TJ, Obana WG, Rosenblum ML (1995) Improved management of multiple brain abscesses: a combined surgical and medical approach. Neurosurgery 36:76–85, discussion 85–76CrossRefPubMed Mamelak AN, Mampalam TJ, Obana WG, Rosenblum ML (1995) Improved management of multiple brain abscesses: a combined surgical and medical approach. Neurosurgery 36:76–85, discussion 85–76CrossRefPubMed
3.
Zurück zum Zitat Toh CH, Wei KC, Ng SH, Wan YL, Lin CP, Castillo M (2011) Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 32:1646–1651CrossRefPubMed Toh CH, Wei KC, Ng SH, Wan YL, Lin CP, Castillo M (2011) Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 32:1646–1651CrossRefPubMed
4.
Zurück zum Zitat Reiche W, Schuchardt V, Hagen T, Il'yasov KA, Billmann P, Weber J (2010) Differential diagnosis of intracranial ring enhancing cystic mass lesions–role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 112:218–225CrossRefPubMed Reiche W, Schuchardt V, Hagen T, Il'yasov KA, Billmann P, Weber J (2010) Differential diagnosis of intracranial ring enhancing cystic mass lesions–role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 112:218–225CrossRefPubMed
5.
Zurück zum Zitat Nath K, Agarwal M, Ramola M et al (2009) Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging 27:198–206CrossRefPubMed Nath K, Agarwal M, Ramola M et al (2009) Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging 27:198–206CrossRefPubMed
6.
Zurück zum Zitat Chiang IC, Hsieh TJ, Chiu ML, Liu GC, Kuo YT, Lin WC (2009) Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging. Br J Radiol 82:813–820CrossRefPubMed Chiang IC, Hsieh TJ, Chiu ML, Liu GC, Kuo YT, Lin WC (2009) Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging. Br J Radiol 82:813–820CrossRefPubMed
7.
Zurück zum Zitat Muccio CF, Esposito G, Bartolini A, Cerase A (2008) Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med (Torino) 113:747–757CrossRef Muccio CF, Esposito G, Bartolini A, Cerase A (2008) Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med (Torino) 113:747–757CrossRef
8.
Zurück zum Zitat Lai PH, Weng HH, Chen CY et al (2008) In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 29:1511–1518CrossRefPubMed Lai PH, Weng HH, Chen CY et al (2008) In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 29:1511–1518CrossRefPubMed
9.
Zurück zum Zitat Lai PH, Hsu SS, Ding SW et al (2007) Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 68:S25–S36CrossRefPubMed Lai PH, Hsu SS, Ding SW et al (2007) Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 68:S25–S36CrossRefPubMed
10.
Zurück zum Zitat Chang SC, Lai PH, Chen WL et al (2002) Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 26:227–236CrossRefPubMed Chang SC, Lai PH, Chen WL et al (2002) Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 26:227–236CrossRefPubMed
11.
Zurück zum Zitat Lai PH, Ho JT, Chen WL et al (2002) Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 23:1369–1377PubMed Lai PH, Ho JT, Chen WL et al (2002) Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 23:1369–1377PubMed
12.
Zurück zum Zitat Mishra AM, Gupta RK, Jaggi RS et al (2004) Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28:540–547CrossRefPubMed Mishra AM, Gupta RK, Jaggi RS et al (2004) Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28:540–547CrossRefPubMed
13.
Zurück zum Zitat Erdogan C, Hakyemez B, Yildirim N, Parlak M (2005) Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr 29:663–667CrossRefPubMed Erdogan C, Hakyemez B, Yildirim N, Parlak M (2005) Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr 29:663–667CrossRefPubMed
14.
Zurück zum Zitat Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM (1997) Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204:272–277CrossRefPubMed Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM (1997) Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204:272–277CrossRefPubMed
15.
Zurück zum Zitat Reichenbach JR, Haacke EM (2001) High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14:453–467CrossRefPubMed Reichenbach JR, Haacke EM (2001) High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14:453–467CrossRefPubMed
16.
Zurück zum Zitat Kim HS, Jahng GH, Ryu CW, Kim SY (2009) Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 30:1574–1579CrossRefPubMed Kim HS, Jahng GH, Ryu CW, Kim SY (2009) Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 30:1574–1579CrossRefPubMed
17.
Zurück zum Zitat Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30:19–30CrossRefPubMedCentralPubMed Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30:19–30CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY (2009) Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 30:1402–1408CrossRefPubMed Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY (2009) Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 30:1402–1408CrossRefPubMed
19.
Zurück zum Zitat Park SM, Kim HS, Jahng GH, Ryu CW, Kim SY (2010) Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol 83:466–475CrossRefPubMedCentralPubMed Park SM, Kim HS, Jahng GH, Ryu CW, Kim SY (2010) Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol 83:466–475CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Lai PH, Chang HC, Chuang TC et al (2012) Susceptibility-weighted imaging in patients with pyogenic brain abscesses at 1.5 T: characteristics of the abscess capsule. AJNR Am J Neuroradiol 33:910–914CrossRefPubMed Lai PH, Chang HC, Chuang TC et al (2012) Susceptibility-weighted imaging in patients with pyogenic brain abscesses at 1.5 T: characteristics of the abscess capsule. AJNR Am J Neuroradiol 33:910–914CrossRefPubMed
21.
Zurück zum Zitat Toh CH, Wei KC, Chang CN et al (2012) Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging. AJNR Am J Neuroradiol 33:1534–1538CrossRefPubMed Toh CH, Wei KC, Chang CN et al (2012) Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging. AJNR Am J Neuroradiol 33:1534–1538CrossRefPubMed
22.
Zurück zum Zitat Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30:232–252CrossRefPubMedCentralPubMed Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30:232–252CrossRefPubMedCentralPubMed
23.
Zurück zum Zitat Wang Y, Yu Y, Li D et al (2000) Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging 12:661–670CrossRefPubMed Wang Y, Yu Y, Li D et al (2000) Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging 12:661–670CrossRefPubMed
24.
Zurück zum Zitat Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM (1997) Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 7:266–279CrossRefPubMed Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM (1997) Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 7:266–279CrossRefPubMed
25.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
26.
Zurück zum Zitat Pinker K, Noebauer-Huhmann IM, Stavrou I et al (2007) High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3 T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 28:1280–1286CrossRefPubMed Pinker K, Noebauer-Huhmann IM, Stavrou I et al (2007) High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3 T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 28:1280–1286CrossRefPubMed
27.
Zurück zum Zitat Li C, Ai B, Li Y, Qi H, Wu L (2010) Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 75:e81–e85CrossRefPubMed Li C, Ai B, Li Y, Qi H, Wu L (2010) Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 75:e81–e85CrossRefPubMed
28.
Zurück zum Zitat Fahrendorf D, Schwindt W, Wolfer J et al (2013) Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme. Eur Radiol 23:2868–2879CrossRefPubMed Fahrendorf D, Schwindt W, Wolfer J et al (2013) Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme. Eur Radiol 23:2868–2879CrossRefPubMed
29.
Zurück zum Zitat Ong BC, Stuckey SL (2010) Susceptibility weighted imaging: a pictorial review. J Med Imaging Radiat Oncol 54:435–449CrossRefPubMed Ong BC, Stuckey SL (2010) Susceptibility weighted imaging: a pictorial review. J Med Imaging Radiat Oncol 54:435–449CrossRefPubMed
30.
Zurück zum Zitat Robinson RJ, Bhuta S (2011) Susceptibility-Weighted Imaging of the Brain: Current Utility and Potential Applications. J Neuroimaging 21:e189–e204CrossRefPubMed Robinson RJ, Bhuta S (2011) Susceptibility-Weighted Imaging of the Brain: Current Utility and Potential Applications. J Neuroimaging 21:e189–e204CrossRefPubMed
31.
Zurück zum Zitat Gupta RK, Tomar V, Awasthi R et al (2012) T2*-weighted MR angiography substantially increases the detection of hemorrhage in the wall of brain abscess: implications in clinical interpretation. Neuroradiology 54:565–572CrossRefPubMed Gupta RK, Tomar V, Awasthi R et al (2012) T2*-weighted MR angiography substantially increases the detection of hemorrhage in the wall of brain abscess: implications in clinical interpretation. Neuroradiology 54:565–572CrossRefPubMed
32.
Zurück zum Zitat Chang HC, Chuang TC, Chung HW et al (2012) Multilayer appearance on contrast-enhanced susceptibility-weighted images on patients with brain abscesses: Possible origins and effects of postprocessing. J Magn Reson Imaging 36:1353–1361CrossRefPubMed Chang HC, Chuang TC, Chung HW et al (2012) Multilayer appearance on contrast-enhanced susceptibility-weighted images on patients with brain abscesses: Possible origins and effects of postprocessing. J Magn Reson Imaging 36:1353–1361CrossRefPubMed
33.
Zurück zum Zitat Britt RH, Enzmann DR, Yeager AS (1981) Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg 55:590–603CrossRefPubMed Britt RH, Enzmann DR, Yeager AS (1981) Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg 55:590–603CrossRefPubMed
34.
Zurück zum Zitat Ferreira NP, Otta GM, do Amaral LL, da Rocha AJ (2005) Imaging aspects of pyogenic infections of the central nervous system. Top Magn Reson Imaging 16:145–154CrossRefPubMed Ferreira NP, Otta GM, do Amaral LL, da Rocha AJ (2005) Imaging aspects of pyogenic infections of the central nervous system. Top Magn Reson Imaging 16:145–154CrossRefPubMed
35.
Zurück zum Zitat Sehgal V, Delproposto Z, Haddar D et al (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41–51CrossRefPubMed Sehgal V, Delproposto Z, Haddar D et al (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41–51CrossRefPubMed
Metadaten
Titel
Discriminating pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors by means of susceptibility-weighted imaging
verfasst von
Jui-Hsun Fu
Tzu-Chao Chuang
Hsiao-Wen Chung
Hing-Chiu Chang
Huey-Shyan Lin
Shu-Shong Hsu
Po-Chin Wang
Shuo-Hsiu Hsu
Huay-Ben Pan
Ping-Hong Lai
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3518-x

Weitere Artikel der Ausgabe 5/2015

European Radiology 5/2015 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.